Stocktoria

Greenland Mines Ltd GRML

Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2022-04-29 · LEI

Greenland Mines Ltd financials (annual)

Revenue
2022202320242025
Net income
$1.2M -$707458 -$6.2M -$10.6M 2022202320242025
Free cash flow
2022202320242025

Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).

MetricFY2025FY2024FY2023FY2022
R&D expense$634,187$0$0
Operating income-$7.1M-$5.5M-$631,322-$657,018
Income tax$690,572$322,025
Net income-$10.6M-$6.2M-$707,458$1.2M
EPS (diluted)$-0.22$-0.32$-0.05
Operating cash flow-$5.9M-$2.9M-$446,916-$493,043
Cash & equivalents$7.2M$63,741$2,808$340,962
Total assets$9.6M$2.5M$2.2M$118.2M
Total liabilities$129,764$1.3M$1.6M$4.9M
Shareholders' equity$9.5M$1.2M-$442,701-$4.0M

Growth · year-over-year

MetricFY2025FY2024FY2023FY2022
Net income growth-157.4%

Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.